blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2498609

EP2498609 - SELECTIVE HETEROCYCLIC SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.02.2019
Database last updated on 20.09.2024
FormerThe patent has been granted
Status updated on  16.03.2018
FormerGrant of patent is intended
Status updated on  13.03.2018
FormerExamination is in progress
Status updated on  16.02.2018
FormerGrant of patent is intended
Status updated on  26.09.2017
FormerExamination is in progress
Status updated on  02.01.2017
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): IS		published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Celgene International II Sàrl
Rue des Moulins
2108 Couvet / CH
[2017/19]
Former [2012/38]For all designated states
Receptos, Inc.
10835 Road to the Cure, 205
San Diego, CA 92121 / US
Inventor(s)01 / BOEHM, Marcus, F.
2811 Maple Street
San Diego, CA 92104 / US
02 / MARTINBOROUGH, Esther
11128 Portobelo Drive
San Diego, CA 92124 / US
03 / BRAHMACHARY, Enugurthi
11795 Spruce Run Dr. No. C
San Diego, CA 92131 / US
04 / MOORJANI, Manisha
8389 Reagan Glen
San Diego, CA 92127 / US
05 / TAMIYA, Junko
258 Argus Way
Oceanside, CA 92057 / US
06 / HUANG, Liming
12788 Adolphia Court
San Diego, CA 92129 / US
07 / YEAGER, Adam, Richard
3468 Copley Avenue
San Diego, CA 92116 / US
 [2018/16]
Former [2012/38]01 / BOEHM, Marcus, F.
2811 Maple Street
San Diego CA 92104 / US
02 / MARTINBOROUGH, Esther
11128 Portobelo Drive
San Diego CA 92124 / US
03 / BRAHMACHARY, Enugurthi
11795 Spruce Run Dr. C
San Diego CA 92131 / US
04 / MOORJANI, Manisha
8389 Reagan Glen
San Diego CA 92127 / US
05 / TAMIYA, Junko
258 Argus Way
Oceanside CA 92057 / US
06 / HUANG, Liming
12788 Adolphia Court
San Diego CA 92129 / US
07 / YEAGER, Adam, Richard
3468 Copley Avenue
San Diego CA 92116 / US
Representative(s)Cohausz & Florack
Patent- & Rechtsanwälte
Partnerschaftsgesellschaft mbB
Bleichstraße 14
40211 Düsseldorf / DE
[2018/16]
Former [2012/38]Cohausz & Florack
Bleichstraße 14
40211 Düsseldorf / DE
Application number, filing date10830879.215.11.2010
[2018/16]
WO2010US56759
Priority number, dateUS20090262474P18.11.2009         Original published format: US 262474 P
US20090261295P13.11.2009         Original published format: US 261295 P
[2012/38]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011060391
Date:19.05.2011
Language:EN
[2011/20]
Type: A1 Application with search report 
No.:EP2498609
Date:19.09.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 19.05.2011 takes the place of the publication of the European patent application.
[2012/38]
Type: B1 Patent specification 
No.:EP2498609
Date:18.04.2018
Language:EN
[2018/16]
Search report(s)International search report - published on:US19.05.2011
(Supplementary) European search report - dispatched on:EP22.04.2013
ClassificationIPC:A01N43/78, A61K31/425
[2012/38]
CPC:
C07D417/12 (EP,CN,KR,US); C07D285/12 (EP,CN,KR,US); C07D277/30 (EP,CN,KR,US);
A61K31/433 (KR); A61K45/06 (KR); A61P1/04 (EP);
A61P11/00 (EP); A61P25/00 (EP); A61P31/16 (EP);
A61P37/06 (EP); A61P43/00 (EP); C07C209/62 (US);
C07C253/30 (US); C07C269/04 (US); C07C29/143 (US);
C07C313/06 (US); C07D285/135 (EP,KR,US); C07D333/24 (EP,CN,KR,US);
C07D333/28 (EP,KR,US); C07D333/38 (EP,US); C07D413/12 (EP,KR,US);
C07D417/10 (EP,CN,US); C07F5/02 (KR,US); C07F7/188 (US);
A61K2300/00 (KR); C07C2602/08 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/38]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:SELEKTIVE HETEROCYCLISCHE SPHINGOSIN-1-PHOSPHATREZEPTORMODULATOREN[2012/38]
English:SELECTIVE HETEROCYCLIC SPHINGOSINE 1 PHOSPHATE RECEPTOR MODULATORS[2012/38]
French:MODULATEURS DE RÉCEPTEUR DE SPHINGOSINE-1-PHOSPHATE HÉTÉROCYCLIQUES SÉLECTIFS[2012/38]
Entry into regional phase06.06.2012National basic fee paid 
06.06.2012Search fee paid 
06.06.2012Designation fee(s) paid 
06.06.2012Examination fee paid 
Examination procedure06.06.2012Examination requested  [2012/38]
20.11.2013Amendment by applicant (claims and/or description)
14.07.2015Despatch of a communication from the examining division (Time limit: M06)
15.01.2016Reply to a communication from the examining division
22.12.2016Despatch of a communication from the examining division (Time limit: M06)
23.06.2017Reply to a communication from the examining division
27.09.2017Communication of intention to grant the patent
02.02.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
02.02.2018Fee for grant paid
02.02.2018Fee for publishing/printing paid
13.03.2018Information about intention to grant a patent
13.03.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.07.2015
Opposition(s)21.01.2019No opposition filed within time limit [2019/13]
Fees paidRenewal fee
26.11.2012Renewal fee patent year 03
27.11.2013Renewal fee patent year 04
26.11.2014Renewal fee patent year 05
30.11.2015Renewal fee patent year 06
28.11.2016Renewal fee patent year 07
27.11.2017Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU15.11.2010
AL18.04.2018
AT18.04.2018
CY18.04.2018
CZ18.04.2018
EE18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
MK18.04.2018
PL18.04.2018
RO18.04.2018
RS18.04.2018
SI18.04.2018
SK18.04.2018
SM18.04.2018
TR18.04.2018
BG18.07.2018
NO18.07.2018
IS18.08.2018
LU15.11.2018
MT15.11.2018
[2020/32]
Former [2020/31]HU15.11.2010
AL18.04.2018
AT18.04.2018
CY18.04.2018
CZ18.04.2018
EE18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
MK18.04.2018
PL18.04.2018
RO18.04.2018
RS18.04.2018
SI18.04.2018
SK18.04.2018
SM18.04.2018
TR18.04.2018
BG18.07.2018
NO18.07.2018
LU15.11.2018
MT15.11.2018
Former [2020/30]HU15.11.2010
AL18.04.2018
AT18.04.2018
CZ18.04.2018
EE18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
PL18.04.2018
RO18.04.2018
RS18.04.2018
SI18.04.2018
SK18.04.2018
SM18.04.2018
TR18.04.2018
BG18.07.2018
NO18.07.2018
LU15.11.2018
MT15.11.2018
Former [2020/16]AL18.04.2018
AT18.04.2018
CZ18.04.2018
EE18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
PL18.04.2018
RO18.04.2018
RS18.04.2018
SI18.04.2018
SK18.04.2018
SM18.04.2018
TR18.04.2018
BG18.07.2018
NO18.07.2018
LU15.11.2018
MT15.11.2018
Former [2020/08]AL18.04.2018
AT18.04.2018
CZ18.04.2018
EE18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
PL18.04.2018
RO18.04.2018
RS18.04.2018
SI18.04.2018
SK18.04.2018
SM18.04.2018
BG18.07.2018
NO18.07.2018
LU15.11.2018
MT15.11.2018
Former [2019/34]AL18.04.2018
AT18.04.2018
CZ18.04.2018
EE18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
PL18.04.2018
RO18.04.2018
RS18.04.2018
SI18.04.2018
SK18.04.2018
SM18.04.2018
BG18.07.2018
NO18.07.2018
LU15.11.2018
Former [2019/33]AL18.04.2018
AT18.04.2018
CZ18.04.2018
EE18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
MC18.04.2018
PL18.04.2018
RO18.04.2018
RS18.04.2018
SI18.04.2018
SK18.04.2018
SM18.04.2018
BG18.07.2018
NO18.07.2018
Former [2019/26]AL18.04.2018
AT18.04.2018
CZ18.04.2018
EE18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
PL18.04.2018
RO18.04.2018
RS18.04.2018
SI18.04.2018
SK18.04.2018
SM18.04.2018
BG18.07.2018
NO18.07.2018
Former [2019/12]AL18.04.2018
AT18.04.2018
CZ18.04.2018
EE18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
PL18.04.2018
RO18.04.2018
RS18.04.2018
SK18.04.2018
SM18.04.2018
BG18.07.2018
NO18.07.2018
Former [2019/10]AL18.04.2018
AT18.04.2018
CZ18.04.2018
EE18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
PL18.04.2018
RO18.04.2018
RS18.04.2018
SK18.04.2018
BG18.07.2018
NO18.07.2018
Former [2019/09]AL18.04.2018
EE18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
PL18.04.2018
RS18.04.2018
BG18.07.2018
NO18.07.2018
Former [2018/51]AL18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
LV18.04.2018
PL18.04.2018
RS18.04.2018
BG18.07.2018
NO18.07.2018
Former [2018/50]AL18.04.2018
FI18.04.2018
HR18.04.2018
LT18.04.2018
PL18.04.2018
BG18.07.2018
NO18.07.2018
Former [2018/47]AL18.04.2018
FI18.04.2018
LT18.04.2018
NO18.07.2018
Former [2018/46]AL18.04.2018
LT18.04.2018
NO18.07.2018
Documents cited:Search[I]WO2004058149  (MERCK & CO INC [US], et al) [I] 1-15* claim 1 *
International search[Y]US6511975  (NISHI TAKAHIDE [JP], et al);
 [Y]US2006161005  (DOHERTY GEORGE A [US], et al);
 [Y]US2008009534  (CHENG PETER T [US], et al);
 [Y]US2008249093  (COLANDREA VINCENT J [US], et al)
by applicant   - LIT et al., "Salt Selection for Basic Drugs", IntJ. Pharm., (19860000), vol. 33, pages 201 - 217
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.